Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Upadacitinib effectively treats psoriasis and lichen planus together.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

A woman with severe angioedema improved significantly after treatment with rituximab.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

3D imaging effectively tracks skin changes in vitiligo treatment.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.